Robert L. van Nostrand - 07 Jan 2026 Form 4 Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
Director
Signature
/s/ Daniel Bagliebter, Power of Attorney for: Robert L. Van Nostrand
Issuer symbol
SLS
Transactions as of
07 Jan 2026
Net transactions value
$0
Form type
4
Filing time
09 Jan 2026, 16:39:03 UTC
Previous filing
13 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
VAN NOSTRAND ROBERT L Director C/O SELLAS LIFE SCIENCES GROUP, INC.,, 7 TIMES SQUARE, SUITE 2503, NEW YORK /s/ Daniel Bagliebter, Power of Attorney for: Robert L. Van Nostrand 09 Jan 2026 0001225198

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLS Common Stock Award $0 +50,000 +152% $0.000000 82,900 07 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.